Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT01108055
Title Phase II Pazopanib in Combination With Weekly Paclitaxel in Refractory Urothelial Cancer
Recruitment Completed
Gender both
Phase Phase II
Variant Requirements No
Sponsors Stanford University

bladder urothelial carcinoma

renal pelvis transitional cell carcinoma

ureter transitional cell carcinoma

urethra transitional cell carcinoma


Paclitaxel + Pazopanib

Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Stanford University School of Medicine Stanford California 94305 United States Details
Karmanos Cancer Institute Detroit Michigan 48201 United States Details
*Shaded cells indicate that there was no data available from for the field